CEQUA “Change the Outlook” (Sun Ophthalmics, Dudnyk)
Dry eye disease affects the ability of your eyes to produce tears, making it difficult to perform everyday activities, such as reading and driving. If left untreated, severe dry eyes may lead to eye inflammation, abrasion of the corneal surface, corneal ulcer, and other vision problems. There are limited prescription treatment options for dry eye disease, and each has its own challenges. To help address these challenges, Sun Ophthalmics and Dudnyk launched a compelling sales aid that positioned CEQUA as a technologically advanced treatment for dry eye disease. CEQUA (cyclosporine ophthalmic solution) 0.09% is a topical solution that helps to increase the production of natural tears in your eye and uses novel NCELL delivery technology to improve drug solubility.
The “Change the Outlook” campaign features the visual of a parched landscape transformed by the CEQUA drop into a lush environment that represents the return of tear production. The interior of the sales aid presents a vivid story of how NCELL technology supports improved ocular penetration of cyclosporine, leading to clinical improvements in healing the ocular surface and restoring health to the eye.
Finally, the imaginative sales aid also helps remind eye care professionals of the seriousness and complexity of dry eye disease, while giving them confidence in knowing they have a new effective option in CEQUA to help relieve their patients’ suffering.
